|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 322.20 SEK | +0.69% |
|
+5.02% | +3.67% |
| 09/02 | DNB Carnegie Raises Price Target for Bioarctic to 342 Kronor (334), Reiterates Buy | FW |
| 09/02 | China Grants Priority Review to BioArctic's Subcutaneous Autoinjector to Treat Early Alzheimer's | MT |
Company Valuation: BioArctic AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 8,401 | 10,497 | 23,972 | 23,651 | 17,634 | 28,560 | 28,560 | - |
| Change | - | 24.95% | 128.37% | -1.34% | -25.44% | 61.97% | 0% | - |
| Enterprise Value (EV) 1 | 7,422 | 9,664 | 23,176 | 23,044 | 17,175 | 26,569 | 26,880 | 26,068 |
| Change | - | 30.21% | 139.82% | -0.57% | -25.47% | 54.69% | 1.17% | -3.02% |
| P/E ratio | -122x | -87.6x | -2,092x | 103x | -99.8x | 28.4x | 139x | 31.3x |
| PBR | 9.26x | 13.3x | 30.5x | 22.6x | 19.7x | 15x | 13.5x | 9.44x |
| PEG | - | -1.2x | 23.1x | -0x | 1x | -0x | -1.7x | 0x |
| Capitalization / Revenue | 127x | 454x | 104x | 38.4x | 68.5x | 14.3x | 25.2x | 15.5x |
| EV / Revenue | 113x | 418x | 101x | 37.4x | 66.7x | 13.3x | 23.7x | 14.1x |
| EV / EBITDA | -100x | -76.3x | -8,251x | 85x | - | 22.3x | 55x | 22.4x |
| EV / EBIT | -87.3x | -69.2x | -1,329x | 91.2x | -75.2x | 22.1x | 83x | 26.3x |
| EV / FCF | -70.8x | -66.7x | -522x | 76.2x | -50.1x | 13.1x | -30.4x | 34x |
| FCF Yield | -1.41% | -1.5% | -0.19% | 1.31% | -2% | 7.62% | -3.29% | 2.94% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.78 | -1.36 | -0.13 | 2.59 | -2 | 11.35 | 2.32 | 10.29 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 65.94 | 23.15 | 229.9 | 616 | 257.4 | 1,994 | 1,133 | 1,843 |
| EBITDA 1 | -74 | -126.6 | -2.809 | 271.1 | - | 1,189 | 489.1 | 1,165 |
| EBIT 1 | -85.01 | -139.7 | -17.44 | 252.6 | -228.5 | 1,203 | 323.7 | 989.4 |
| Net income 1 | -68.52 | -119.8 | -11.18 | 229.2 | -177.1 | 1,002 | 204.8 | 912.1 |
| Net Debt 1 | -979.2 | -832.5 | -795.3 | -606.6 | -458.7 | -1,992 | -1,680 | -2,492 |
| Reference price 2 | 95.40 | 119.20 | 272.00 | 267.80 | 199.50 | 322.20 | 322.20 | 322.20 |
| Nbr of stocks (in thousands) | 88,060 | 88,060 | 88,132 | 88,315 | 88,389 | 88,641 | 88,641 | - |
| Announcement Date | 04/02/21 | 03/02/22 | 03/02/23 | 14/02/24 | 13/02/25 | - | - | - |
1SEK in Million2SEK
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 28.39x | 13.33x | 22.35x | -.--% | 319.5Cr | |
| 36.46x | 5.29x | 17.74x | 0.94% | 4.76TCr | |
| 106.75x | 6.78x | 68.17x | -.--% | 3.83TCr | |
| 63.2x | 12.9x | 36.08x | 0.3% | 3.61TCr | |
| 23.6x | 2.57x | 11.02x | -.--% | 2.83TCr | |
| -17.24x | 4584.51x | -15.9x | -.--% | 1.86TCr | |
| 25.15x | 2.07x | 9.27x | 0.97% | 1.37TCr | |
| 37.23x | 7.56x | 23.78x | -.--% | 1.33TCr | |
| -35.61x | 13.49x | -38.5x | -.--% | 1.31TCr | |
| Average | 29.77x | 516.50x | 14.89x | 0.25% | 2.36TCr | |
| Weighted average by Cap. | 42.03x | 408.87x | 22.55x | 0.33% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- BIOA B Stock
- Valuation BioArctic AB
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition